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Abstract: The ubiquitin–proteasome system (UPS) and the autophagy–lysosomal pathway (ALP) are
the two main eukaryotic intracellular proteolytic systems involved in maintaining proteostasis. Several
studies have reported on the interplay between the UPS and ALP, however it remains largely unknown
how compromised autophagy affects UPS function in vivo. Here, we have studied the crosstalk
between the UPS and ALP by investigating the tissue-specific effect of autophagy genes on the UPS at
an organismal level. Using transgenic Caenorhabditis elegans expressing fluorescent UPS reporters,
we show that the downregulation of the autophagy genes lgg-1 and lgg-2 (ATG8/LC3/GABARAP),
bec-1 (BECLIN1), atg-7 (ATG7) and epg-5 (mEPG5) by RNAi decreases proteasomal degradation,
concomitant with the accumulation of polyubiquitinated proteasomal substrates in a tissue-specific
manner. For some of these genes, the changes in proteasomal degradation occur without a detectable
alteration in proteasome tissue expression levels. In addition, the lgg-1 RNAi-induced reduction
in proteasome activity in intestinal cells is not dependent on sqst-1/p62 accumulation. Our results
illustrate that compromised autophagy can affect UPS in a tissue-specific manner, and demonstrate
that UPS does not function as a direct compensatory mechanism in an animal. Further, a more
profound understanding of the multilayered crosstalk between UPS and ALP can facilitate the
development of therapeutic options for various disorders linked to dysfunction in proteostasis.
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1. Introduction
Protein homeostasis (proteostasis) is a dynamic balance between protein biogenesis and
degradation, and is essential for cell survival and growth. The pool of intracellular and various
extracellular proteins is constantly being replaced by newly synthesized proteins, and therefore protein
degradation must be selective and tightly regulated. In eukaryotes, the ubiquitin–proteasome system
(UPS) and autophagy–lysosome pathway (ALP) are the two major intracellular proteolytic systems
that mediate protein turnover.
UPS is the main pathway responsible for the degradation of soluble and short-lived misfolded
proteins, both in the cytosol and the nucleus. Proteasomal substrates are first polyubiquitinated
via the action of three classes of enzymes: ubiquitin-activating enzymes (E1), ubiquitin-conjugating
enzymes (E2) and ubiquitin ligases (E3), reviewed in [1,2]. The substrates are then degraded by the
evolutionarily conserved 26S proteasome, which consists of a central barrel-shaped core particle (CP or
20S proteasome) enclosing the peptide hydrolysis activity of the complex. The 20S comprises four
stacked heteroheptameric rings: two rings of α subunits at each end and two middle β subunit rings
harboring the proteolytic activities. The 20S core particle is capped by one or two 19S regulatory
particles (RP), required for substrate recognition, the removal of the attached ubiquitin chains,
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the ATP-dependent unfolding of the substrate, and transfer into the core for proteolysis, as reviewed
in [3–5].
Long-lived misfolded proteins and defective cellular organelles are in turn degraded by the ALP.
There are three main types of autophagy reviewed in [6], including macroautophagy, hereafter
referred to as autophagy. The initiation of autophagy starts by the formation of an isolation
membrane, the phagophore, which elongates to engulf the substrate(s), thus forming the double-layered
autophagosome. This then fuses with late endosomes and lysosomes, leading to the formation of
autolysosomes, where the substrate(s) is degraded by lysosomal hydrolases [2,7,8]. Autophagy is
mediated through the conserved action of several proteins, from yeast to mammalian cells. A class-III
phosphatidylinositol 3-kinase (PI3K) complex, together with lipid kinase VPS34 and the regulatory
protein Beclin1, initiate the autophagic process by mediating vesicle nucleation. Two ubiquitin-like
conjugation systems, encoded by the autophagy-related genes (atg), then regulate the elongation
of the isolation membrane. The first conjugation system comprises ATG-12 and ATG-5, conjugated
via a covalent bond mediated by the E1-like ATG-7 and E2-like ATG-10. The second conjugation
system involves ATG-8, which conjugates with lipid phosphatidylethanolamine in a process regulated
by ATG-7 and the E3-like ATG-3. The ATG-5-ATG-12 conjugate is detached after autophagosome
formation, whereas ATG-8 remains in the autophagosome in its conjugated form. Currently, yeast
ATG-8 and its mammalian homolog LC3 are the most commonly used markers for autophagic
activity [9–12]. Another set of proteins functions at the last fusion step. RAB-7, a member of the
Rab GTPase family, is present in late endosomes, and is involved in regulating the fusion to late
lysosomes [12]. Additionally, mEPG-5 is required for the maturation of autophagosomes and their
fusion to lysosomes [13,14]. The activation of autophagy can be induced by several stimuli, such as
amino-acid deprivation, starvation or various stress conditions [15,16].
The UPS and ALP were previously believed to have exceedingly distinct substrates, and they were
regarded as independent proteolytic systems, but accumulating evidence has established extensive
crosstalk between the two, reviewed in [17]. Several studies using human cell lines and mice
have reported that pharmacological and genetic inhibition of the UPS leads to the activation of
autophagy [18–21]. However, the blocking of autophagy has reportedly more complex and contrasting
results, both inhibiting and activating UPS [22–25].
Both the autophagy pathway and the UPS are highly conserved in the nematode Caenorhabditis
elegans, reviewed in [26–28]. It has been reported that the rate of autophagic flux can vary in different
C. elegans tissues during aging and stress [29,30]. Similarly, we have previously shown that UPS
activity varies in a tissue-specific manner in C. elegans [31–33]. Here, we have investigated the crosstalk
between UPS and ALP at an organismal level using C. elegans. We reveal that the downregulation
of certain autophagy genes that function at different ALP steps elicits distinct tissue-specific effects
on UPS in C. elegans, and that the observed changes in proteasomal degradation can occur either
concomitant with, or without, a detectable change in proteasome tissue expression levels.
2. Material and Methods
2.1. C. elegans and Growth Conditions
C. elegans strains were grown and maintained under standard conditions at 20 ◦C as described
previously [34]. N2 (Bristol) and MAH215 strains were obtained from the Caenorhabditis Genetics
Center (CGC). NL2099[rrf-3(pk1426)II] mutant strain was a kind gift from Dr. G. Wong (University of
Eastern Finland). YD116[rrf-3(pk1426);xzIs2[unc-54p::UIM2::ZsProSensor]] reporter strain was generated
by crossing NL2099[rrf-3(pk1426)II] strain with YD114[xzIs2[unc-54p::UIM2::ZsProSensor]] [35].
Information on the cloning of the plasmid has been described previously in Matilainen et al., 2013, as a
precursor for the YD90[xzIs1[vha-6p::UIM2::ZsProSensor]] strain [32]. All strains used in this study are
listed in Table S1.
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2.2. C. elegans RNA Interference (RNAi)
RNAi was performed using the previously described feeding protocol [36]. The HT115 bacterial
strain carrying the empty pL4440 expression vector was used as a control in all experiments. Double
stranded RNA expression was induced by adding 0.4 mM of isopropyl-β-D-thiogalactopyranoside
(I6758, Sigma, St. Louis, MO, USA) during peak culture growth and its concentration was further
increased to 0.8 mM just prior to the seeding of the feeding plates. Unless otherwise indicated,
age-synchronized L1 larvae (day 1) were placed on control and RNAi-seeded plates, targeting either
lgg-1, lgg-2, bec-1, atg-7, rab-7, epg-5 or sqst-1 (C32D5.9, ZK593.6, T19E7.3, M7.5, W03C9.3, C56C10.12 or
T12G3.1, respectively, Source BioScience, J. Ahringer library). Double RNAi of lgg-1 and sqst-1 was
performed by mixing lgg-1 and sqst-1 RNAi cultures in 1:1 ratio according to their optical density prior
to seeding.
2.3. Microscopy and Image Analysis
Age-synchronized animals were imaged at first day of adulthood (day 4). Groups of animals
were mounted on 3% agarose pad on glass slides and immobilized using 0.5 mM levamisole diluted
in M9 buffer. The polyubiquitin reporter animals were imaged with a Zeiss Axio Imager upright
epifluorescence microscope using 10× 0.3 NA EC Plan Neofluar objective. Images were quantified
using the Fiji ImageJ software.
For the UbG76V-Dendra2 and Dendra2 strains, images of a group of animals were taken before
and immediately after proteins were converted from green to red fluorescence using 405 nm UV
light (considered 0 h after conversion). Animals were recovered on corresponding feeding plates and
reimaged after 6 h (intestinal reporter strains) or 24 h (body-wall muscle reporter strains). A Zeiss
Axio Imager Z2 upright epifluorescence microscope was used for photoconversion and images were
acquired with a 10 × 0.3 NA EC Plan Neofluar objective. Fluorescent intensities were quantified
using the Fiji ImageJ software. Relative intensities were calculated by setting the absolute values
of fluorescence intensity before and after photoconversion as 100%, for green and red fluorescence
signals, respectively. For both the polyubiquitin reporter and the UPS activity reporter, images were
exported into tiff-format and quantified using the original black and white version of the images
without modifications. The background was subtracted using the corresponding command in Fiji
software. The threshold was selected from the brightest image and this same threshold was applied to
all images from the same experiment. The average of mean intensity was analyzed.
The autophagy dual marker reporter strain was imaged using Zeiss LSM880 confocal microscope
(Motorized Zeiss Axio Observer Z1 inverted microscope). Z-stack images were acquired at 0.8 µm
slice intervals with a 63× 1.4 NA plan-Apochromat objective. The z-stack images were converted to
maximum intensity projection format using ZEN 2.1 (black version) and converted to tiff-format using
Zen 2 lite (blue version). The number of puncta was calculated manually.
All images were processed with Adobe Photoshop CC 2018 software. When the brightness of an
image was increased to make the fluorescent signal clearly visible, all corresponding images from the
same experiment were modified in the same way. The number of animals imaged for each treatment
and their p-values relative to the control are listed in Tables S2, S3 and S5 for the polyubiquitin reporter,
UPS activity reporter and autophagy dual marker reporter, respectively.
2.4. Quantitative Real-Time PCR
Age-synchronized RNAi-treated animals were collected in M9 buffer at first day of adulthood
(day 4) and stored at −80 ◦C. Total RNA was extracted using NucleoSpin RNA kit (Macherey-Nagel,
Düren, Germany) and RNA concentration was measured with Nanodrop spectrophotometer at 260 nm.
RT-PCR was performed using Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Scientific,
Waltham, MA, USA). The quantitative real-time PCR was done using Maxima SYBR Green/ROX qPCR
Master Mix (2X) (Thermo Scientific) and LightCycler 480 (Roche, Basel, Switzerland) quantitative PCR
Cells 2020, 9, 1858 4 of 16
machine. The data from qPCR were normalized to the geometric mean of mRNA concentration of three
reference genes (act-1, cdc-42 and pmp-3) [37]. The qPCR oligos used in this study are listed in Table S6.
2.5. In-Gel Proteasome Activity Assay and Western Blotting
RNAi-treated age-synchronized young adult (day 4) rrf-3(pk1426) animals were collected in
M9 buffer prior to freezing at −80 ◦C for both the in-gel activity assay and Western blot samples.
For in-gel activity assay, the animals were lysed in native gel lysis buffer using Dounce homogenizer
as previously described [38]. The in-gel assay was performed as described earlier, but with slight
modifications [32,38]. The native 3.5% acrylamide gels were run for 30 min at 20 mA and then for 2 h
at 40 mA on an ice bath in a cold room (+4 ◦C). The gels were developed using developing buffer
including 80 µM of the fluorogenic proteasome substrate suc-LLVY-AMC (I-1395, Bachem, Bubendorf,
Switzerland). The gels were imaged with MultiImage Light Cabinet using FluorChem 8900 software
(Alpha Innotech Corporation). After imaging, Coomassie staining of the gels was performed using
Colloidal Blue Staining Kit (Invitrogen) to assess sample loading. The fluorescent signal was modified
similarly for all images from the same experiment with Adobe Photoshop CC 2018 software, and signal
intensities were quantified using Fiji ImageJ software.
For Western blotting, the animals were lysed either according to the native gel protocol (detection of
proteasome 20S alpha subunits) or by sonication using Western blot lysis buffer (50 mM Hepes (pH 7.4),
150 mM NaCl, 5 mM EDTA, 20 mM NEM, 10 µM MG-132 and protease inhibitor cocktail (Roche);
detection of polyubiquitinated proteins). Samples were run on SDS-PAGE gel and immunoblotted
onto a nitrocellulose membrane using Trans-Blot Turbo transfer system (Bio-Rad). Anti-20S alpha
antibody (for proteasome 20S α-subunits 1–3 and 5–7, BML-PW8195, Enzo Life Sciences, 1:1000
dilution), FK-1 antibody (for polyubiquitinated proteins, BML-PW8805, Enzo Life Sciences, 1:500
dilution) and anti-α-tubulin antibody (for α-tubulin, T5168, Sigma, 1:10 000 dilution) were used
for immunoblotting. The secondary antibodies for the proteasome 20S α-subunits and α-tubulin
were anti-mouse IgG-HRP conjugates (W4021, Promega, 1:10,000 dilution), and anti-mouse IgM-HRP
conjugates (401225, Calbiochem, 1:10,000 dilution) were used for polyubiquitinated proteins. Image
Studio software (Licor) was used for imaging and quantifying the signals. A summary of the number
of experiments and p-values relative to the respective controls is included in Table S4.
2.6. Immunohistochemical Analysis
Age-synchronized young adult (day 4) animals were collected in M9 buffer and fixed with 10%
(v/v) phosphate buffered formalin as described earlier [33]. The fixed animals were embedded in
2% agar and the paraffin-embedded agar blocks were cut into 4 µm sections. Immunohistochemical
staining was performed using Dako REALTM EnVisionTM Detection System, Peroxidase/DAB+,
Rabbit/mouse kit (Dako) and the anti-20S alpha antibody (BML-PW8195, Enzo Life Sciences, 1:1000
dilution) [33]. The staining specificity of the anti-20S alpha antibody was previously established in
C. elegans by omitting the primary antibody or by pre-absorption with purified 20S proteasome [33].
The stained slides were imaged with a Zeiss Axio Imager Z2 upright epifluorescence microscope
using 10× 0.3 NA EC Plan Neofluar objective or 63× 1.4 NA Plan-Apochromat objective. Images were
converted to tiff-format using Zen 2 lite (blue version). Immunostaining evaluation was performed
independently and blindly by three investigators without prior knowledge of original treatment
conditions. Staining intensity was scored as 0 for negative, 1 for mild, 2 for moderate and 3 for strong
positive immunoreactivity. Information on the number of experiments and p-values relative to controls
is presented in Table S4.
2.7. Statistical Analysis
Statistical significance was determined using the student’s t-test (two-tailed) in all quantifications
and the treated group was compared to either control or to another treatment, as indicated in the figures.
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3. Results
3.1. Downregulation of Autophagy Genes Affects the Accumulation of Polyubiquitinated Proteins in a
Tissue-Specific Manner In Vivo
To investigate the interconnection between the UPS and autophagy at an organismal level,
we downregulated the autophagy genes influencing different stages of ALP (Figure S1A) and analyzed
the subsequent effects on the UPS in C. elegans. The RNAi-sensitive rrf-3(pk1426) strain was exposed
to various RNAi treatments, targeting the individual autophagy genes lgg-1, lgg-2 (homologs of
mammalian LC3/GABARAP), bec-1 (BECLIN 1), atg-7 (ATG7), rab-7 or epg-5 (mEPG-5) (Figure S1B),
resulting in a clear downregulation of their corresponding mRNA levels (Figure S1C). To monitor
the outcome from the compromised autophagy gene expression, we used the dual fluorescence
mCherry::GFP::LGG-1 reporter strain [29] to quantify the number of autophagosomes (APs) present in
the live animals. As expected, RNAi against lgg-1 or bec-1 decreased the number of puncta that were
positive for autophagosomes, whereas knockdown of lgg-2, atg-7, rab-7 or epg-5 significantly increased
the formation of APs (Figure S2A, Table S5), validating our experimental setup.
Next, we investigated the accumulation of polyubiquitinated proteins in live animals using our
previously developed tissue-specific fluorescent polyubiquitin reporter, which binds to endogenous
Lys-48-linked polyubiquitinated proteasomal substrates [32,39]. An increase in the fluorescence of the
reporter corresponded with an accumulation of proteasomal substrates upon impaired proteasome
function. Interestingly, animals expressing the polyubiquitin reporter in intestinal cells displayed
increased accumulation of polyubiquitinated proteins upon introduction of RNAi against lgg-1, lgg-2,
bec-1 or atg-7 (Figure 1A,C, Table S2). In contrast, the downregulation of rab-7 or epg-5 did not affect
the reporter fluorescence in intestinal cells (Figure 1A,C). Additionally, we examined the effect of
the knockdown of autophagy genes in animals expressing the polyubiquitin reporter in body-wall
muscle cells.
Our results revealed that lgg-2, bec-1 or epg-5 RNAi increased the amounts of polyubiquitinated
proteins in these cells, whereas lgg-1, atg-7 or rab-7 RNAi did not change the intensity of reporter
fluorescence (Figure 1B,D, Table S2). When we investigated the total amounts of polyubiquitinated
proteins present in whole animal lysates by Western blotting, we did not detect any differences between
the control and RNAi-treated animals (Figure S3A,B). Taken together, our data indicate the tissue-specific
effect of certain autophagy genes on the accumulation of polyubiquitinated proteasomal substrates.
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1, lgg-2, bec-1, atg-7, rab-7 or epg-5 RNAi-treated animals expressing the polyubiquitin reporter in the 
intestinal (A) and body-wall muscle (B) cells, respectively. Quantification of the fluorescent signal of 
the polyubiquitin reporter in intestinal (C) and body-wall muscle (D) cells, respectively. Graphs show 
average fold change in the amount of fluorescence signal compared to control RNAi (set as 1). Results 
are the mean of quantifications from 6 independent experiments (n = number of animals) (See Table 
S2). Error bars, SEM, * p < 0.05 and ** p < 0.01 compared to the control. 
Figure 1. Downregulation of autophagy genes affects accumulation of fluorescent polyubiquitin
reporters in a tissue-specific manner in vivo. Representative fluorescence micrographs of control, lgg-1,
lgg-2, bec-1, atg-7, rab-7 or epg-5 RNAi-treated animals expressing the polyubiquitin reporter in the
intestinal (A) and body-wall muscle (B) cells, respectively. Quantification of the fluorescent signal of
the polyubiquitin reporter in intestinal (C) and body-wall muscle (D) cells, respectively. Graphs show
average fold change in the amount of fluorescence signal compared to control RNAi (set as 1). Results
are the mean of quantifications from 6 independent experiments (n = number of animals) (See Table S2).
Error bars, SEM, * p < 0.05 and ** p < 0.01 compared to the control.
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3.2. Tissue-Specific Differences in UPS Activity In Vivo Upon Knockdown of Autophagy Genes
Next, we wanted to investigate whether the observed tissue-specific accumulation of
polyubiquitinated proteins upon downregulation of autophagy genes could be a result of changes in
proteasome activity. For this purpose, we took advantage of our previously generated photoconvertible
UPS reporter system, which is based on the photoswitchable green-to-red fluorescent protein Dendra2
fused to the non-hydrolyzable ubiquitin moiety UbG76V [32,40]. The UbG76V-Dendra2 is targeted by
the UPS, and degraded by the proteasome. After an UV light-induced photoconversion, the decrease
in red fluorescence intensity of UbG76V-Dendra2 over time reflects UPS-mediated protein degradation,
and in a manner independent of the translation of new reporter proteins. Here, we examined whether
the modulation of autophagy gene expression directly affects the degradation of UbG76V-Dendra2 in
different tissues.
Animals expressing UbG76V-Dendra2 in intestinal cells were fed either control, lgg-1, lgg-2,
bec-1, atg-7, rab-7 or epg-5 RNAi bacteria, and analyzed for potential changes in reporter degradation.
Six hours after photoconversion, approximately 10–12% of UbG76V-Dendra2 had been degraded in
the lgg-1, lgg-2, bec-1 or atg-7 RNAi-treated animals, compared with the roughly 30% degradation
rate observed in control animals (Figure 2A,B, Table S3). This slower degradation correlates with
the increased accumulation of polyubiquitinated proteins (Figure 1A,C). In agreement with these
results, RNAi against rab-7 or epg-5 did not affect UPS activity in intestinal cells (Figure 2A,B, Table S3).
In contrast, the degradation rate of the UbG76V-Dendra2 reporter in body-wall muscle cells changed
solely upon epg-5 RNAi, resulting in approximately 15% difference compared with the control
(Figure 3A,B, Table S3). Surprisingly, we did not detect a change in reporter degradation upon lgg-2
and bec-1 RNAi, although these treatments caused the accumulation of polyubiquitin reporter in
the muscle cells. Further, the fluorescence in animals expressing the control Dendra2 in intestinal
or body-wall muscle cells remained stable after RNAi against autophagy genes over the measured
time period (Figures S4 and S5, Table S3). Altogether, our data demonstrate that the knockdown of
specific autophagy genes induces distinct effects on UPS activity in intestinal and body-wall muscle
cells in vivo.
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Figure 2. RNAi of lgg-1, lgg-2, bec-1 or atg-7 decreases UPS activity in intestinal cells in vivo. (A) The
images represent fluorescent micrographs of control, lgg-1, lgg-2, bec-1, atg-7, rab-7 or epg-5 RNAi-treated
N2 animals expressing UbG76V-Dendra2 reporter in intestinal cells before, immediately after and
6 h after photoconversion. (B) Quantification of UbG76V-Dendra2 degradation rate in intestinal cells.
Graph shows the average percentage of green or red fluorescence relative to initial fluorescence intensity
(set as 100%), or intensity at the point of photoconversion (set as 100%), respectively. The decrease in
red fluorescence of UbG76V-Dendra2 reflects the UPS activity in the tissue. Results are the mean of
quantification of 5 independent experiments (number of animals (n) = 105) (See Table S3). Error bars,
SEM, ** p < 0.01 and *** p < 0.001 compared to the control.
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Figure 3. RNAi of epg-5 decreases UPS activity in body-wall muscle cells in vivo. (A) The images
represent fluorescent micrographs of control, lgg-1, lgg-2, bec-1, atg-7, rab-7 or epg-5 RNAi-treated
wild-type animals expressing the UbG76V-Dendra2 reporter in body-wall muscle cells before,
immediately after and 24 h after photoconversion. (B) Quantification of UbG76V-Dendra2 degradation
rate in body-wall muscle cells. Graph shows the average percentage of green or red fluorescence
relative to initial fluorescence intensity (set as 100%), or intensity at the point of photoconversion (set as
100%), respectively. The decrease in red fluorescence of UbG76V-Dendra2 reflects the UPS activity in
the tissue. Results are the mean of quantification of 5 independent experiments (number of animals
(n) = 100) (See Table S3). Error bars, SEM, ** p < 0.01 compared to the control.
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3.3. Downregulation of lgg-1 Affects UPS Function Independently of p62/SQST-1 Accumulation
Previous studies have reported that polyubiquitinated proteins accumulate in mammalian cells
upon autophagy inhibition via a process mediated by increased levels of the autophagosome cargo
protein p62 [23,41]. We performed RNAi against sqst-1, the C. elegans homolog of mammalian p62,
in combination with lgg-1 RNAi to prevent p62 accumulation. Simultaneous downregulation of these
two genes did not counteract the lgg-1 RNAi-induced accumulation of polyubiquitinated proteins,
nor the reduction in proteasomal substrate degradation in intestinal cells (Figure 4A,B). This suggests
that the decreased UPS activity observed upon lgg-1 RNAi is independent of sqst-1 upregulation,
as sqst-1 mRNA levels were efficiently decreased upon both single or double gene RNAi treatment
(Figure S1D). sqst-1 RNAi alone did not elicit an effect on proteasome activity in intestinal cells
(Figure 4A,B). Our data imply that modulating autophagy via decreased lgg-1 expression leads to
impaired proteasome activity, in a SQST-1-independent manner, in C. elegans intestinal cells.
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Figure 4. lgg-1 RNAi affects UPS function independently of SQST-1. (A) Quantification of polyubiquitin
reporter fluorescence in intestinal cells upon control, lgg-1, sqst-1 or combined sqst-1 and lgg-1 RNAi.
Graphs show average fold change in the amount of fluorescent signal compared to control RNAi
treatment (set as 1). Results are the mean of quantifications of 4 independent experiments (number of
animals ( ) = 90). (B) Quantification of UbG76V-Dendra2 degradation rate in intestinal cells. Graph
shows the average percentage of red fluorescence remaining 6 h after photoconversion upon respective
RNAi treatments. Results are the mean of quantification of 3 independent experiments (number of
a imals (n) = 65) (See Tables S2 and S3). Error bars, SEM, * p < 0.05, ** p < 0.01, and n.s. = non-significant
compared to control or indicated treatment.
3.4. Depletion of Autophagy Genes Affects Proteasome Activity or Expression
In addition to the UPS in vivo experiments, we investigated proteasome activity in whole animal
lysates by performing an in-gel activity assay whereby the lysates were resolved on a native acrylamide
gel, and the in-gel activity was measured with the fluorogenic suc-LLVY-AMC proteasome substrate [38].
Knockdown of lgg-1 or epg-5 by RNAi decreased proteasome activity by approximately 0.2-fold,
compared to the control (Figure 5A,B, Table S4), which is in agreement with our in vivo data (Figures 2A,B
and 3A,B, Table S3). Interestingly, we did not detect any effect on proteasome activity after lgg-2, bec-1
or atg-7 RNAi treatments (Figure 5A,B, Table S4), suggesting that the in vivo tissue-specific proteasome
activity responses (Figures 2 and 3, Table S3) are masked in whole animal lysates.
We next investigated total proteasome amounts in whole worm lysates with Western blot, using
an antibody against proteasome 20S alpha sub nits. The do nregulation of lgg-2 or bec-1 resulted
in approximately a 0.2-fold decrease in total proteasome abundance, whereas no change could be
detected with lgg-1, atg-7, rab-7 or epg-5 RNAi (Figure 5C,D, Table S4).
Taken together, our in vivo and in vitro results reveal that the depletion of autophagy genes causes
different proteasomal responses, i.e., lgg-1 and epg-5 RNAi modulate proteasome activity without
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detectably changing its level, whereas lgg-2 and bec-1 RNAi in turn decrease total proteasome amount
in whole animal lysates without causing changes in proteasome activity.
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investigated by in-gel activity assay with flu rogenic suc-LLVY-AMC proteasome substrate from
whol animal lysates of rrf-3(pk1426) animals treated with control, lgg-1, lgg-2, bec-1, atg-7, rab-7 or
epg-5 RNAi (upper panel), and Coomassie staining of total protein of the same gel (lower panel).
The marker lines represe t RP2-CP, RP-CP and CP, respectively. (B) Quantification of in-g l prot asom
activity. The bands corresponding to RP2-CP, RP-CP and CP were used for quantification. Graph sh ws
average fold change in fluorescent signal compared to co trol RNAi (set as 1). Results are the mean
of quantifications from 10 independent experiments (See Table S4). Error bars, SEM, ** p < 0.01 and
*** p < 0.001 compared to the control. (C) Lysates of rrf-3(pk1426) animals treated with control, lgg-1,
lgg-2, bec-1, atg-7, rab-7 or epg-5 RNAi separated on SDS-PAGE and immunoblotted against proteasome
20S alpha subunits (upper panel) and α-tubulin (lower panel). (D) Quantification of proteasome
immunoblots. Graph shows average fold change in levels of 20S alpha subunits normalized against
α-tubulin. Results are the mean of quantifications from 7 independent experiments (See Table S4).
Error bars, SEM, ** p < 0.01 compared to the control.
3.5. RNAi of lgg-2 or bec-1 Causes Distinct Responses in Proteasome Tissue Expression
To further investigate proteasome expression at the tissue and cell resolution level in C. elegans,
we used an immunohistochemical approach for the detection of the 20S proteasome [33]. In support
of our Western blot data from the whole animal lysates, we detected decreased proteasome amounts
after the downregulation of lgg-2 or bec-1 by RNAi (Figure 6). Importantly, the decrease in proteasome
expr ssion was not niform, but displayed distinct tissue-specificity. bec-1 RNAi decreased t
amount in both intestinal and body-wall muscle cells (approximately by 0.25-fold compared to control
RNAi, Figur 6A–D, Table S4), whereas lgg-2 RNAi caused a de rease in proteaso e expression on y
in the body-wall muscle cells (approximately by 0.2-fold, Figure 6C,D, Table S4). In agreement with
our W stern blot analysis, o changes were detected with epg-5, lgg-1, atg-7 or rab-7 RNAi (Figure 6
and Figure S6, Table S4). Altogether, our studies reveal that the downregulation of various autophagy
genes leads to distinct responses in proteasome tissue expression levels.
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Figure 6. Knockdown of lgg-2 and bec-1 results in tissue-specific proteasome expression responses.
(A) Images representing proteasome immunoreactivity of rrf-3(pk1426) animals treated with control,
lgg-2, bec-1 or epg-5 RNAi in the intestinal cells (indicated by white arrowheads). (B) Quantification
of immunoreactivity in intestinal cells. Graph shows the average fold change in staining intensity of
20S alpha antibody compared to control treatment (set as 1). Results are the mean of quantifications
from 3 independent experiments (number of intestinal cells (n) = 80) (See Table S4). Error bars, SEM,
** p < 0.01 compared to the control. (C) Higher magnification images of rrf-3(pk1426) animals treated
with control, lgg-2, bec-1 or epg-5 RNAi in the body-wall muscle cells (outlined with white dash line).
(D) Quantification of immunoreactivity in the body-wall muscle cells. Graph shows the average fold
change in staining intensity against 20S alpha antibody. Results are the mean of quantifications from
3 independent experiments (number of muscle cells (n) = 45) (See Table S4). Error bars, SEM, * p < 0.05,
** p < 0.01 compared to control.
4. Discussion
In this study, we use C. elegans as an organismal approach to evaluate for the first time how
compromising autophagy at different steps affects UPS in different tissues. We show that individual
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depletions of several autophagy genes cause tissue-specific effects on UPS activity and proteasome
abundance. Though several previous studies using cell lines and mice have shown that the impairment
of proteasome function results in the induction of autophagy [18–21,42,43], studies on the inhibition
of autophagy have reported more complex results, including both UPS activation and inhibition.
For example, the pharmacological inhibition of autophagy and the knockdown of Atg-5 or Atg-7
in human colon cancer cell lines have been shown to increase proteasomal activity [24]. Similarly,
Kim et al. reported that Atg-5 deficient mouse embryonic fibroblast exhibited elevated proteasome
activity [22]. On the other hand, Atg-7 deficient mouse neurons display accumulations of ubiquitinated
substrates without observed changes in proteasomal function [44]. Additionally, Korolchuk et al.
reported that arresting autophagy by siRNA knockdown of Atg-7 and Atg-12, or with autophagy
inhibitors, causes impaired degradation of at least two proteasomal substrates, UbG76V-GFP and p53,
in HeLa cells, although without affecting total proteasome activity in the cell lysates [23]. Furthermore,
autophagy blockage due to lysosomal enzymatic deficiency causes decreased proteasomal activity
in neuroblastoma cells [25]. Here, we show that downregulation of bec-1, atg-7, lgg-1, lgg-2 or epg-5
impairs UPS function in C. elegans. Importantly, our results reveal that, depending on which autophagy
gene is depleted, the effect on UPS varies. For example, downregulation of lgg-1 or epg-5 by RNAi
affects the UPS and proteasomal activity in in vivo and in vitro assays, without a concomitant change
in proteasome expression, whereas lgg-2 or bec-1 RNAi decreases UPS activity in vivo, as well as the
amount of the proteasome (Figures 2, 3, 5 and 6). The results of lgg-1 and epg-5 RNAi suggest that their
effect could be mediated through a regulator of the proteasome. In line with this suggestion, we have
previously shown that the proteasome-associated deubiquitinase UBH-4 regulates proteasome activity
in C. elegans in an insulin/IGF-1 signaling-mediated manner [32], and that animals with mutations in
this pathway display altered proteasome activity without a concomitant change in proteasome tissue
expression [32,33]. Further studies are needed to uncover the underlying mechanisms of lgg-1 and
epg-5 knockdown in proteasome activity.
Our previous research has demonstrated that UPS activity varies in a tissue-specific manner in live
C. elegans, and is affected by aging and stress, such as proteasomal impairment and elevated growth
temperature [31,32,35]. The rate of autophagic flux has also been reported to vary in different C. elegans
tissues [29,30]. Chang et al. showed that autophagy activity declines in several tissues in wild-type
animals, whereas long-lived mutants display spatiotemporal regulation of autophagy [29]. Additionally,
Chapin et al. reported that both basal autophagy as well as stress-induced autophagy can vary in
different tissues [30]. Recently, it was shown that affecting proteostasis through the downregulation of
chaperones involved in disaggregation results in increased autophagy and decreased UPS in C. elegans
and human HEK293 cells [45]. Interestingly, the same study revealed that both autophagy and
UPS are impaired in tissues expressing the human disease-linked amyloid protein Aβ3–42 and Q40
in C. elegans [45]. Here, we reveal that a widespread downregulation of distinct autophagy genes
generates tissue-specific UPS responses. We show that the downregulation of bec-1, lgg-1, lgg-2 and
atg-7 decreases UPS activity in intestinal cells, whereas epg-5 RNAi affects UPS activity in muscle
cells (Figures 2 and 3). Similarly, we detect tissue-specific decreases in proteasome expression upon
autophagy impairment, as bec-1 RNAi decreases the amount of proteasome in both intestinal and
muscle cells, but lgg-2 RNAi affects proteasome expression only in muscle cells (Figure 6). This tissue
specificity is not due to a difference in RNAi efficiency, as gene-specific RNAi phenotypes are observed
for both cell types. It is noteworthy that our data suggest that a particular proteasomal substrate can
be degraded while some substrates accumulate upon compromised autophagy.
Our experimental approaches for studying UPS activity and proteasome expression enable us
to perform intra-tissue analysis at the organismal level. The bec-1 RNAi-induced accumulations
of the UPS substrate UbG76V-Dendra2, as well as those of the endogenous pool of K-48-linked
polyubiquitinated proteins in the intestine, coincided with the decreased expression of proteasome
in the same tissue, thus displaying a mechanism by which BEC-1 affects intestinal UPS function.
The instances wherein we did not observe a correlation between changes in proteasome level and UPS
Cells 2020, 9, 1858 14 of 16
activity (i.e., downregulation of lgg-1, lgg-2, atg-7 and epg-5) could be due to, for example, changes
in substrate delivery to the proteasome, posttranslational modifications, or proteasome interaction
with regulators. Korolchuk et al. has demonstrated that, in HeLa cells, the accumulation of distinct
proteasomal substrates upon compromised autophagy is dependent on increased p62 levels without a
change in proteasome activity, suggesting difficulties in substrate delivery to the proteasome [23]. Here,
we show that the accumulation of endogenous K-48-linked polyubiquitinated proteasomal substrates,
as well as the decreased degradation of the proteasomal substrate UbG76V-Dendra2 upon impaired
autophagy by lgg-1 RNAi, is independent of increased levels of SQST-1 in C. elegans intestinal cells.
As p62/SQST-1 has preference for binding to K-63-linked polyubiquitinated proteins [46], this may
explain why the pool of endogenous K-48-linked proteasomal substrates is not affected. Moreover,
it was recently shown that overexpression of sqst-1 in C. elegans leads to a modest increase in proteasome
activity, and a reduced amount of ubiquitinated proteins, as analyzed in whole animal lysates [47].
Our data demonstrate that UPS does not function as a direct compensatory mechanism upon
ALP impairment in a multicellular organism. Importantly, our results emphasize the existence of
tissue-specific responses in UPS activity and proteasome expression to disturbed autophagy. Whilst
previous research has largely focused on how UPS and autophagy are individually regulated, our study
provides new information that could be implemented for the simultaneous modulation of UPS
and ALP. This is of particular interest, as dysfunctions in these proteolytic systems are associated
with various, often aging-related, disorders, such as neurodegenerative diseases (e.g., Parkinson’s
disease and Alzheimer’s disease), autoimmune diseases and different types of cancer. In particular,
the tissue-specific effects of autophagy gene depletions on UPS revealed here could provide insight
into designing therapies for altering proteasome activity in a specific tissue. Our results create further
interest in discovering the mechanisms by which the depletion of different autophagy genes elicits
distinct UPS responses. More detailed understanding of UPS and ALP, and their multifaceted crosstalk
in varying physiological conditions, will increase our understanding of proteostasis regulation.
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